Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sackstein

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Human Pathology|July 1, 1996
Cutaneous CD56+ large T-cell lymphoma associated with high serum concentration of IL-2M A Wasik, R Sackstein, D Novick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2001
A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responsesM A Exley, S M Tahir, O Cheng, et al.
Bone Marrow Transplantation|February 2, 2000
High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II studyH C Toh, S L McAfee, R Sackstein, et al.
Cell|June 1, 1984
Expression of hemolytically active murine fourth component of complement in transfected L cellsD D Chaplin, R Sackstein, D H Perlmutter, et al.
Transplantation|February 1, 2000
Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swineC Colby, Q Chang, Y Fuchimoto, et al.
Lancet (London, England)|May 29, 1999
Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantationM Sykes, F Preffer, S McAfee, et al.
Transplantation|September 10, 1999
Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerismT R Spitzer, F Delmonico, N Tolkoff-Rubin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantationB R Dey, S McAfee, R Sackstein, et al.
Biochimica Et Biophysica Acta. General Subjects|May 20, 2018
A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancerM A Carrascal, M Silva, J A Ferreira, et al.
Transplantation|July 4, 2001
Mechanisms of thrombotic microangiopathy following xenogeneic hematopoietic progenitor cell transplantationI P Alwayn, L Buhler, J Z Appel, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Human Pathology|July 1, 1996
Cutaneous CD56+ large T-cell lymphoma associated with high serum concentration of IL-2M A Wasik, R Sackstein, D Novick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2001
A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responsesM A Exley, S M Tahir, O Cheng, et al.
Bone Marrow Transplantation|February 2, 2000
High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II studyH C Toh, S L McAfee, R Sackstein, et al.
Cell|June 1, 1984
Expression of hemolytically active murine fourth component of complement in transfected L cellsD D Chaplin, R Sackstein, D H Perlmutter, et al.
Transplantation|February 1, 2000
Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swineC Colby, Q Chang, Y Fuchimoto, et al.
Lancet (London, England)|May 29, 1999
Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantationM Sykes, F Preffer, S McAfee, et al.
Transplantation|September 10, 1999
Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerismT R Spitzer, F Delmonico, N Tolkoff-Rubin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantationB R Dey, S McAfee, R Sackstein, et al.
Biochimica Et Biophysica Acta. General Subjects|May 20, 2018
A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancerM A Carrascal, M Silva, J A Ferreira, et al.
Transplantation|July 4, 2001
Mechanisms of thrombotic microangiopathy following xenogeneic hematopoietic progenitor cell transplantationI P Alwayn, L Buhler, J Z Appel, et al.
Pageof 4